Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mesa Laboratories (MLAB) Free Cash Flow (2016 - 2025)

Historic Free Cash Flow for Mesa Laboratories (MLAB) over the last 16 years, with Q4 2025 value amounting to $18.0 million.

  • Mesa Laboratories' Free Cash Flow rose 407.72% to $18.0 million in Q4 2025 from the same period last year, while for Dec 2025 it was $37.9 million, marking a year-over-year decrease of 1175.61%. This contributed to the annual value of $42.6 million for FY2025, which is 238.9% up from last year.
  • Per Mesa Laboratories' latest filing, its Free Cash Flow stood at $18.0 million for Q4 2025, which was up 407.72% from $7.1 million recorded in Q3 2025.
  • Over the past 5 years, Mesa Laboratories' Free Cash Flow peaked at $18.0 million during Q4 2025, and registered a low of -$3.0 million during Q2 2022.
  • Its 5-year average for Free Cash Flow is $9.0 million, with a median of $9.4 million in 2023.
  • As far as peak fluctuations go, Mesa Laboratories' Free Cash Flow plummeted by 13397.49% in 2022, and later surged by 41847.83% in 2023.
  • Quarter analysis of 5 years shows Mesa Laboratories' Free Cash Flow stood at $13.8 million in 2021, then tumbled by 56.18% to $6.1 million in 2022, then skyrocketed by 71.62% to $10.4 million in 2023, then surged by 66.39% to $17.3 million in 2024, then increased by 4.08% to $18.0 million in 2025.
  • Its Free Cash Flow was $18.0 million in Q4 2025, compared to $7.1 million in Q3 2025 and $884000.0 in Q2 2025.